Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
Anne Puel(Inserm), Jean‐Laurent Casanova(Howard Hughes Medical Institute), A. Toulon(Délégation Paris 5), O Marie(Hôpital Necker-Enfants Malades), Dinakantha Kumararatne(Hôpital Necker-Enfants Malades), Alain Fischer(Inserm), Peter D. Arkwright(University of Manchester), Aurélie Cobat(Délégation Paris 5), Amit Nahum(University of Toronto), Stéphane Blanche(Hôpital Necker-Enfants Malades), Vivienne McConnell(University of Ulster), Capucine Pïcard(Délégation Paris 5), Christine Bodemer(Hôpital Necker-Enfants Malades), Colm Costigan(Children's Health Ireland at Crumlin), Michel Polak(Hôpital Necker-Enfants Malades), Maya Chrabieh(Inserm), Jacinta Bustamante(Inserm), Gabriela Barcenas‐Morales(Universidad de Cuautitlán Izcalli), Chaim M. Roifman(University of Toronto), Angels Natividad(Délégation Paris 5), Mario Abinun(North Tyneside General Hospital), Laurent Abel(Inserm), Pierre-François Bougnères(Hôpital Saint-Vincent-de-Paul), Desa Lilić(Newcastle University), Mohammed Al‐Owain(King Faisal Specialist Hospital & Research Centre), Saleh Al‐Muhsen(King Saud University), Rainer Döffinger(Hôpital Necker-Enfants Malades), Andrew J. Cant(Clinical Research Institute), László Maródi(University of Debrecen)
Cited by 721
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k